Global Companion Animal Postoperative Pain Management Therapeutics Market by Animal Type (Feline, Canine), by Product (Anesthetics, NSAIDs) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global companion animal postoperative pain management therapeutics market was valued at USD 228,90 million in 2018. It is forecast to grow 6.7% over the forecast period. Postoperative pain relief is in high demand due to the increase in pet surgery, particularly orthopedic and dental. Dental surgeries will be more in demand due to the rising incidence of periodontal disease. The AMA report states that clinic visits for dogs rose by 6% between 2014 and 2017, owing to an increase in dental problems. Increasing companion animal ownership is expected to drive further revenue growth.
The market will be further fueled by rising disposable income in both developing and industrialized countries. According to the American Veterinary Medical Association's (AVMA) report, U.S. pet owners spent USD 15.42 billion on veterinary surgery in 2017. In 2017, around 20 million dogs underwent surgery. Among them, 5 million experienced post-operative pain.
The market for companion animal pain management therapeutics is expected to grow because of the increased adoption of NSAIDs following the restriction of opioids' use to manage postoperative pain. The demand for companion pain-relieving drugs is expected to rise due to increased concerns from pet owners and decreased use of off-label human opioids. Industry players are developing these drugs to address the unmet demand for local anesthetics that work long-lastingly for small animals. In situ Biologics' AniGelSR has demonstrated 72-hour efficacy during a preclinical study to manage post-operative pain. The FDA has yet to approve the drug, which will increase the market revenue over the next few years.
According to the Animal Cancer Foundation in 2017, the United States had approximately 65 million dogs and 32 millions cats. The growing number of pet clinics and veterinary hospitals is fueling the market for companion animal pain management therapeutics. The American Veterinary Medical Association's (AVMA) report states that the U.S. private practice for small animals increased 14% in 2018.
There are strict regulations regarding the use of opioids in animals and humans. This makes it less popular as a post-operative pain reliever. Around 40% of U.S. veterinarians prescribed opioids to animals for perioperative care in 2014. The U.S. FDA issued guidelines in 2017 regarding safe opioid use in pets. These guidelines require that veterinarians be licensed by Drug Enforcement to prescribe opioids to pets. A survey done by AVMA found that 44% of opioids had been misused or abused in 2018. 11% of pet owners were also intentionally hurting their pets to obtain opioids. These factors will likely limit the growth in opioids and increase revenue for postoperative pain relief drugs in the near future.
Product Insights
Due to their easy availability, the NSAIDs market dominated 2018 with a 45.0% revenue share. These drugs are used to control inflammation and pain following surgery. NSAIDs are much less expensive than opioids and anesthetics, which helps to increase its revenues. Previcox, Metacam, Deramaxx and Rimadyl (injectable) are some of the most popular NSAIDs used for post-operative pain management. Market players are working to create innovative NSAIDs that can be used for peri-operative pain management. Elanco was approved for Onsior in May 2016 for the treatment of pain after soft tissue surgery in dogs.
Over the forecast period, steady growth is expected in the anesthetics market. Lidocaine, bupivacaine, and other anesthetics are used frequently. An AVMA report shows that around 5 million dogs experienced post-operative pain in 2016. As pet owners want to bring their pets home following surgery, the demand for long-acting or control-release local anesthetics is growing. Nocita, a post-operative pain medication that can control pain for up 72 hours, was launched by Aratana Therapeutics in 2016.
Information on Animal Types
Due to an increase in surgeries, canines accounted for the largest share of the market in 2018. One of the key growth drivers is the rise in chronic diseases in dogs. The most common surgeries on dogs include dental, hip dysplasia and cataract surgery. All of these surgeries require ongoing care. The growth is expected to be further accelerated by the increasing adoption of dogs in households both in developing and developed countries.
Over the forecast period, the feline market is expected to grow at a steady rate. This steady growth can be attributed primarily to cat owners' increasing concerns about post-operative pain management for their cats. Another major driver of growth is the increase in cat surgeries. UTI, bladder stones, kidney disease, eye and dental problems, as well as ear infections, are the most common ailments in cats. The growth of cat adoptions in Europe and Asia is accelerating. In 2018, for example, the European feline population was 102.69 millions while the European canine population was only 84.91million. It is expected that favorable insurance policies will further increase the growth of this segment.
Regional Insights
In 2018, North America held the largest revenue share. The region's favorable healthcare system and rising government initiatives are expected to drive growth. The region is expected to see an increase in pet ownership and a growing demand for quality animal care. This will create revenue generation opportunities. The demand for pain management therapies for companion animals will rise due to the rising incidence of chronic diseases in pets. The market is also experiencing a rise in the number of veterinary procedures, particularly orthopedic and dental. According to the APPA report in 2018, Americans spent approximately USD 18.11 billion on veterinary services. This is due to the presence of industry giants such as Merck, Elanco and Zoetis boosting regional growth.
The availability of better treatments for companion animals is also a result of pet insurance's increasing demand. A report by the North American Pet Health Insurance Association, (NAPHIA) states that more than 2 million pets were insure in the U.S. and Canada in 2017. This represents an average increase of almost 17% over the previous year.
Over the forecasted time, Asia Pacific will experience a lucrative CAGR. The increasing prevalence of chronic diseases has resulted in an increase of companion animal surgeries. The market is expected to grow due to increasing pet ownership in Japan and China. According to the National Bureau of Statistics of China (NBS), China ranked third worldwide in dog ownership in 2017 with 27.4million pet dogs, just behind the United States (55.3 million) or Brazil (35.7 million). High demand for insurance policies further drives revenue generation in the region. According to the 2018 Pet Industry White Paper, Japan's pet owners spend approximately USD 740 per pet.
Market Share insights for Companion Animal Postoperative pain Management Therapeutics
This market is fragmented and marked by both small and large companies. Norbrook, Bayer AG and Elanco are the major market players. To increase market share, the companies are involved in strategic initiatives such as regional expansions. New product launches. Collaborations. Mergers and acquisitions.
Elanco purchased Aratana Therapeutics in April 2019 to increase its product range in pain management for companion animals. Ceva Polchem, a global hub for innovation in companion animal health, consolidated its Laval, France business in June 2019. This will increase the company's R&D capabilities on the market.
Companion Animal Postoperative pain Management Therapeutics Market Report Scope
Report Attribute |
More Details |
The 2020 market size value |
USD 256.59 Million |
2026 revenue forecast |
USD 382.36 Million |
Growth Rate |
CAGR of 6.7% between 2019 and 2026 |
Base year for estimation |
2018 |
Historical data |
2014 - 2017 |
Forecast period |
2019 - 2026 |
Quantitative units |
From 2019 to 2026, revenue in USD millions and CAGR |
Report coverage |
Forecast revenue, company ranking and competitive landscape, growth factors and trends |
Segments covered |
Product, animal type, and region |
Regional scope |
North America; Europe; APAC, Latin America; MEA |
Country coverage |
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Japan; China; India; Brazil; Mexico; South Africa |
Key companies profiled |
Zoetis; Bayer AG; Elanco; Ceva; Norbrook |
The scope of customization |
With purchase, you get free report customization (equivalent to up to 8 analysts working day) You can add or modify country, region and segment scope. |
Prices and purchase options |
You can get customized purchase options that meet your research needs. Explore your purchase options |
The Report Covers Certain Segments
This report predicts revenue growth at the global, regional and country level and offers an analysis of industry trends in each sub-segment from 2014 to 2026. Grand View Research has divided the global companion animal postoperative pain relief therapeutics market report by product, region, and animal type.
-
Product Outlook (Revenue USD Million, 2014-2026)
-
NSAIDs
-
Anesthetics
-
Opioids
-
Other
-
-
The Animal Type Outlook (Revenue USD Million, 2014-2026)
-
Canine
-
Feline
-
-
Regional Outlook (Revenue USD Million, 2014-2026)
-
North America
-
The U.S.
-
Canada
-
-
Europe
-
U.K.
-
Germany
-
France
-
Italy
-
Spain
-
-
Asia Pacific
-
Japan
-
China
-
India
-
-
Latin America
-
Brazil
-
Mexico
-
-
Middle East & Africa
-
South Africa
-
-
These are the most frequently asked questions about this report
What is the market size for companion animals in post-operative pain management therapeutics?b. Global companion animal postoperative pain management therapeutics market was valued at USD 242.07 Million in 2019. It is projected to grow to USD 256.59 Million in 2020.
What is the postoperative pain management market growth companion animal?b. Global companion animal postoperative pain management therapeutics market will grow at 6.7% compound annual growth rate from 2019 to 2026, to reach USD 382.36 millions by 2026.
Which market segment had the largest postoperative pain management therapeutics market for companion animals?b. With a 32.20% share in 2019, North America dominated companion animal postoperative pain management therapeutics. This can be attributed to increasing pet ownership and increased demand for quality animal care.
What are the major players in the companion animal postoperative pain management therapeutics industry?b. Some of the key players in the companion animal postoperative pain relief therapeutics market are Zoetis and Bayer AG. Elanco, Ceva, Norbrook, and Ceva.
What factors drive the postoperative pain management therapeutics market for companion animals?b. b.
Up Market Research published a new report titled “Companion Animal Postoperative Pain Management Therapeutics Market research report which is segmented by Animal Type (Feline, Canine), by Product (Anesthetics, NSAIDs), By Players/Companies Bayer AG, Elanco, Ceva, Norbrook, Zoetis”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
Report Attributes | Report Details |
Report Title | Companion Animal Postoperative Pain Management Therapeutics Market Research Report |
By Animal Type | Feline, Canine |
By Product | Anesthetics, NSAIDs |
By Companies | Bayer AG, Elanco, Ceva, Norbrook, Zoetis |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 205 |
Number of Tables & Figures | 144 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Companion Animal Postoperative Pain Management Therapeutics Market Report Segments:
The market is segmented by Animal Type (Feline, Canine), by Product (Anesthetics, NSAIDs).
Companion Animal Postoperative Pain Management Therapeutics Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Companion Animal Postoperative Pain Management Therapeutics Market
Overview of the regional outlook of the Companion Animal Postoperative Pain Management Therapeutics Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Companion Animal Postoperative Pain Management Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Companion Animal Postoperative Pain Management Therapeutics Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Feline
2. Canine
7. By Product:1. Anesthetics
2. NSAIDs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Companion Animal Postoperative Pain Management Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Companion Animal Postoperative Pain Management Therapeutics Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Companion Animal Postoperative Pain Management Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Companion Animal Postoperative Pain Management Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Companion Animal Postoperative Pain Management Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Companion Animal Postoperative Pain Management Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Companion Animal Postoperative Pain Management Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Companion Animal Postoperative Pain Management Therapeutics Market Size and Y-o-Y Growth
4.5.2 Companion Animal Postoperative Pain Management Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Companion Animal Postoperative Pain Management Therapeutics Market Analysis and Forecast by Animal Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Animal Type
5.1.2 Basis Point Share (BPS) Analysis by Animal Type
5.1.3 Absolute $ Opportunity Assessment by Animal Type
5.2 Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Animal Type
5.2.1 Feline
5.2.2 Canine
5.3 Market Attractiveness Analysis by Animal Type
Chapter 6 Global Companion Animal Postoperative Pain Management Therapeutics Market Analysis and Forecast by Product
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Product
6.1.2 Basis Point Share (BPS) Analysis by Product
6.1.3 Absolute $ Opportunity Assessment by Product
6.2 Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Product
6.2.1 Anesthetics
6.2.2 NSAIDs
6.3 Market Attractiveness Analysis by Product
Chapter 7 Global Companion Animal Postoperative Pain Management Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Companion Animal Postoperative Pain Management Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Animal Type
9.6.1 Feline
9.6.2 Canine
9.7 Basis Point Share (BPS) Analysis by Animal Type
9.8 Absolute $ Opportunity Assessment by Animal Type
9.9 Market Attractiveness Analysis by Animal Type
9.10 North America Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Product
9.10.1 Anesthetics
9.10.2 NSAIDs
9.11 Basis Point Share (BPS) Analysis by Product
9.12 Absolute $ Opportunity Assessment by Product
9.13 Market Attractiveness Analysis by Product
Chapter 10 Europe Companion Animal Postoperative Pain Management Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Animal Type
10.6.1 Feline
10.6.2 Canine
10.7 Basis Point Share (BPS) Analysis by Animal Type
10.8 Absolute $ Opportunity Assessment by Animal Type
10.9 Market Attractiveness Analysis by Animal Type
10.10 Europe Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Product
10.10.1 Anesthetics
10.10.2 NSAIDs
10.11 Basis Point Share (BPS) Analysis by Product
10.12 Absolute $ Opportunity Assessment by Product
10.13 Market Attractiveness Analysis by Product
Chapter 11 Asia Pacific Companion Animal Postoperative Pain Management Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Animal Type
11.6.1 Feline
11.6.2 Canine
11.7 Basis Point Share (BPS) Analysis by Animal Type
11.8 Absolute $ Opportunity Assessment by Animal Type
11.9 Market Attractiveness Analysis by Animal Type
11.10 Asia Pacific Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Product
11.10.1 Anesthetics
11.10.2 NSAIDs
11.11 Basis Point Share (BPS) Analysis by Product
11.12 Absolute $ Opportunity Assessment by Product
11.13 Market Attractiveness Analysis by Product
Chapter 12 Latin America Companion Animal Postoperative Pain Management Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Animal Type
12.6.1 Feline
12.6.2 Canine
12.7 Basis Point Share (BPS) Analysis by Animal Type
12.8 Absolute $ Opportunity Assessment by Animal Type
12.9 Market Attractiveness Analysis by Animal Type
12.10 Latin America Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Product
12.10.1 Anesthetics
12.10.2 NSAIDs
12.11 Basis Point Share (BPS) Analysis by Product
12.12 Absolute $ Opportunity Assessment by Product
12.13 Market Attractiveness Analysis by Product
Chapter 13 Middle East & Africa (MEA) Companion Animal Postoperative Pain Management Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Animal Type
13.6.1 Feline
13.6.2 Canine
13.7 Basis Point Share (BPS) Analysis by Animal Type
13.8 Absolute $ Opportunity Assessment by Animal Type
13.9 Market Attractiveness Analysis by Animal Type
13.10 Middle East & Africa (MEA) Companion Animal Postoperative Pain Management Therapeutics Market Size Forecast by Product
13.10.1 Anesthetics
13.10.2 NSAIDs
13.11 Basis Point Share (BPS) Analysis by Product
13.12 Absolute $ Opportunity Assessment by Product
13.13 Market Attractiveness Analysis by Product
Chapter 14 Competition Landscape
14.1 Companion Animal Postoperative Pain Management Therapeutics Market: Competitive Dashboard
14.2 Global Companion Animal Postoperative Pain Management Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer AG
14.3.2 Elanco
14.3.3 Ceva
14.3.4 Norbrook
14.3.5 Zoetis